Ivan Bergstein, Chief Executive Officer at STEMLINE THERAPEUTICS INC (STML), sold 90,866 shares at $10.58 ($987K) on 2019-12-23, disclosed to the SEC on 2020-01-03.
Open-market sale of $987k STML by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.58 | 5,225 | $55K | 5.6% |
| 2 | $10.58 | 5,225 | $55K | 5.6% |
| 3 | $10.97 | 29,613 | $325K | 32.9% |
| 4 | $10.97 | 29,613 | $325K | 32.9% |
| 5 | $10.75 | 18,744 | $201K | 20.4% |
| 6 | $10.48 | 2,446 |
| $26K |
| 2.6% |
| Total | $10.87 avg | 90,866 | $987K | 100% |
| Filing → |
| STML | SELL | 2020-02-28 | $316K | — | Filing → |
| STML | SELL | 2019-08-16 | $1.0M | — | Filing → |
| STML | SELL | 2019-06-28 | $1.3M | — | Filing → |